Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESPECT: Trastuzumab monotherapy vs combination in elderly HER2+ breast cancer
NCT01104935Phase 3Completed
- Sponsor
- Comprehensive Support Project for Oncology Research
- Start
- Oct 2009
- Primary completion
- Oct 2017
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of trastuzumab in breast cancer, sponsored by Comprehensive Support Project for Oncology Research. Started Oct 2009; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01104935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01104935.